Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.

Bioorg Med Chem Lett

Medicinal Chemistry Pharmacology Groups, NPS Pharmaceuticals, Inc., Salt Lake City, UT 84108, USA.

Published: November 2000

The stereoselective synthesis and biological activity of NPS 1407 (4a), (S)-(-)-3-amino-1,1-bis(3-fluorophenyl)butane, a potent, stereoselective antagonist of the NMDA receptor, are described. The racemate (4) was found to be active at the NMDA receptor in an in vitro assay, prompting the synthesis of the individual stereoisomers. The S isomer (4a) was found to be 12 times more potent than the R isomer (4b). Compound 4a demonstrated in vivo pharmacological activity in neuroprotection and anticonvulsant assays.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(00)00470-4DOI Listing

Publication Analysis

Top Keywords

nmda receptor
12
nps 1407
8
potent stereoselective
8
chiral synthesis
4
synthesis pharmacological
4
pharmacological evaluation
4
evaluation nps
4
1407 potent
4
stereoselective nmda
4
receptor antagonist
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!